The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ADMA BIOLOGICS INC COM 000899104 576 315,000 SH   SOLE   315,000 0 0
ALPHATEC HLDGS INC COM NEW 02081G201 2,678 232,864 SH   SOLE   232,864 0 0
APOLLO ENDOSURGERY INC COM 03767D108 4,472 739,165 SH   SOLE   739,165 0 0
BERKELEY LTS INC COM 084310101 2,840 399,402 SH   SOLE   399,402 0 0
CVRX INC COM 126638105 3,236 540,273 SH   SOLE   540,273 0 0
IRHYTHM TECHNOLOGIES INC COM 450056106 1,244 7,898 SH   SOLE   7,898 0 0
NEURONETICS INC COM 64131A105 2,897 955,999 SH   SOLE   955,999 0 0
RENALYTIX PLC ADS 75973T101 3,179 459,461 SH   SOLE   459,461 0 0
SERA PROGNOSTICS INC CLASS A COM 81749D107 3,521 929,073 SH   SOLE   929,073 0 0
STEREOTAXIS INC COM NEW 85916J409 2,265 607,269 SH   SOLE   607,269 0 0
THE ONCOLOGY INSTITUTE INC COM 68236X100 3,167 444,244 SH   SOLE   444,244 0 0
VAPOTHERM INC COM 922107107 18,461 1,328,109 SH   SOLE   1,328,109 0 0